Dr. Martens PLC Cash Flow Conversion Efficiency
Dr. Martens PLC cash flow conversion efficiency. Based on the latest financial reports, Dr. Martens PLC (DOCS) has a cash flow conversion efficiency ratio of 0.392x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX141.60 Million ≈ $17.23K USD) by net assets (GBX361.50 Million ≈ $43.98K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Dr. Martens PLC (2014–2026)
Cash flow conversion efficiency of Dr. Martens PLC from 2014 to 2026. This chart illustrates how Dr. Martens PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dr. Martens PLC (DOCS) stock price for real-time trading data and today's change.
Dr. Martens PLC Cash Flow Conversion Ratio Explained
Dr. Martens PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Dr. Martens PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dr. Martens PLC ranked by their cash flow conversion efficiency. Also see Dr. Martens PLC (DOCS) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jayud Global Logistics Limited Class A Ordinary Shares
NASDAQ:JYD
|
-0.365x |
|
DIGIDRIVE DISTRIBUTORS LTD
NSE:DIGIDRIVE
|
-0.008x |
|
Pharmacielo Ltd
V:PCLO
|
0.236x |
|
Jcurve Solutions Ltd
AU:JCS
|
0.778x |
|
Scodix Ltd
TA:SCDX
|
-0.550x |
|
Fastpasscorp A/S
CO:FASTPC
|
0.246x |
|
SEL Manufacturing Company Limited
NSE:SELMC
|
-0.098x |
|
Ebang International Holdings
NASDAQ:EBON
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Dr. Martens PLC (2014–2026)
The table below shows the annual cash flow conversion efficiency of Dr. Martens PLC from 2014 to 2026. Review Dr. Martens PLC (DOCS) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | GBX361.50 Million ≈ $43.98K |
GBX125.50 Million ≈ $15.27K |
0.347x | -35.20% |
| 2025-03-31 | GBX366.40 Million ≈ $44.58K |
GBX196.30 Million ≈ $23.88K |
0.536x | +17.49% |
| 2024-03-31 | GBX368.20 Million ≈ $44.80K |
GBX167.90 Million ≈ $20.43K |
0.456x | +138.44% |
| 2023-03-31 | GBX404.20 Million ≈ $49.18K |
GBX77.30 Million ≈ $9.41K |
0.191x | -65.96% |
| 2022-03-31 | GBX328.20 Million ≈ $39.93K |
GBX184.40 Million ≈ $22.44K |
0.562x | -30.25% |
| 2021-03-31 | GBX150.70 Million ≈ $18.34K |
GBX121.40 Million ≈ $14.77K |
0.806x | -53.22% |
| 2020-03-31 | GBX70.50 Million ≈ $8.58K |
GBX121.40 Million ≈ $14.77K |
1.722x | +125.83% |
| 2019-03-31 | GBX-8.40 Million ≈ $-1.02K |
GBX56.00 Million ≈ $6.81K |
-6.667x | -326.09% |
| 2018-03-31 | GBX-29.40 Million ≈ $-3.58K |
GBX46.00 Million ≈ $5.60K |
-1.565x | +18.13% |
| 2017-03-31 | GBX-18.00 Million ≈ $-2.19K |
GBX34.40 Million ≈ $4.19K |
-1.911x | +18.52% |
| 2016-03-31 | GBX-11.00 Million ≈ $-1.34K |
GBX25.80 Million ≈ $3.14K |
-2.345x | -109.48% |
| 2015-03-31 | GBX800.00K ≈ $97.34 |
GBX19.80 Million ≈ $2.41K |
24.750x | +643.39% |
| 2014-03-31 | GBX1.51 Million ≈ $183.60 |
GBX5.02 Million ≈ $611.28 |
3.329x | -- |
About Dr. Martens PLC
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.